Comparison of the effectiveness of mindfulness and cognitive-behavioral therapy on blood sugar and glycosylated hemoglobin in patients with type 2 diabetes

Document Type : Research Paper

Authors

1 Department of Psychology, Kish International Branch, Islamic Azad University, Kish Island, Iran

2 Professor, Department of Psychology, Allameh Tabatabai University, Tehran, Iran

3 Associate Professor of Endocrinology, Ministry of Health and Medical Education, Tehran, Iran.

4 Professor, Department of Psychology, Kharazmi University, Tehran, Iran.

Abstract

Abstract
Introduction: Patients with diabetes have a major problem with metabolic control; The aim of this study was to determine and compare the effectiveness of mindfulness and cognitive-behavioral therapy on metabolic control (glycosylated hemoglobin and blood sugar) of type 2 diabetes patients.
Methods: The research method was semi-experimental with pre-test-post-test design with control group and two-month follow-up test. 45 people from the community of people with type 2 diabetes were selected in the available method in the Diabetes Association of Tehran in 1398 and were randomly replaced in two experimental and control groups. The required findings were collected using medical experiments three times before, after, and follow-up tests and were analyzed using variance analysis with repeated measurements.
Results: The results of repeated measurement analysis of variance showed that mindfulness and cognitive-behavioral interventions are effective in reducing blood sugar and glycosylated hemoglobin in diabetic patients (p <0.001). Ben-Ferroni's test showed that the effect of mindfulness was significantly higher than the swimming-t-behavioral method (p <0.001).
Conclusion: Despite the methodological-behavioral effect on the metabolic control of diabetic patients, it is recommended to use mindfulness-based intervention for better control.

Keywords

References

  1. American Diabetes Association. 7. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care
    in Diabetes-2018. Diabetes care. 2018 Jan;41(Suppl 1):S65.
    2. Deacon CF. Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes. Peptides. 2018 Feb
    1;100:150-7.
    3. Atlas D. International diabetes federation. IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes
    Federation. 2015.
    4. RakhshanehRou S, Ghaffari M, HeydarNia A, Rajab A. Effectiveness of educational intervention on metabolic control of
    diabetic patients referred to the Iranian Diabetes Association. Iranian Journal of Diabetes and Metabolism. 2011; 9 (2): 57-
    64
    5. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes research and
    clinical practice. 2010 Jan 1;87(1):4-14.
    6. Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy.
    Diabetes/metabolism research and reviews. 2012 Feb; 28:8-14.
    7. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn
    AL, Lindgren CM. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.
    Nature genetics. 2010 Feb;42(2):105.
    8. Xu Y, Zhao Z, Li X, Bi Y, Xu M, Ning G. Relationships between C-reactive protein, white blood cell count, and insulin
    resistance in a Chinese population. Endocrine. 2011 Apr 1;39(2):175-81.
    9. Thong EP, Codner E, Laven JS, Teede H. Diabetes: a metabolic and reproductive disorder in women. The Lancet Diabetes
    & Endocrinology. 2020 Feb 1;8(2):134-49.
    10. Ataie Moghanloo V, Ataie Moghanloo R, Moazezi M. Effectiveness of Acceptance and Commitment Therapy for
    Depression Psychological WellBeing and feeling of Guilt, Iran J Pediatr 2015; 25(4): 24-36.
    11. Slavich GM, Taylor S, Picard RW. Stress measurement using speech: Recent advancements, validation issues, and ethical
    and privacy considerations. Stress. 2019 Jul 4;22(4):408-13.
    12. Roemer L, Williston SK, Rollins LG. Mindfulness and emotion regulation. Current Opinion in Psychology. 2015 Jun
    1;3:52-7.
    13. Abbott RA, Whear R, Rodgers LR, Bethel A, Coon JT, Kuyken W, Stein K, Dickens C. Effectiveness of mindfulnessbased stress reduction and mindfulness based cognitive therapy in vascular disease: A systematic review and meta-analysis
    of randomised controlled trials. Journal of psychosomatic research. 2014 May 1;76(5):341-51.
    14. Kabat-Zinn J. Mindfulness for beginners: Reclaiming the present moment—and your life. Sounds True; 2012.
    15. Schroevers MJ, Tovote KA, Keers JC, Links TP, Sanderman R, Fleer J. Individual mindfulness-based cognitive therapy for
    people with diabetes: A pilot randomized controlled trial. Mindfulness. 2015 Feb 1;6(1):99-110.
    16. Oraki M, sami P. The Effect of Mindfulness Integrated BehaviorCognitive Therapy on psychological well-being and
    quality of life among multiple sclerosis patients. Health Psychology. 2017; 3 (5): 34-47.
    17. van Son J, Nyklíček I, Pop VJ, Blonk MC, Erdtsieck RJ, Pouwer F. Mindfulness-based cognitive therapy for people with
    diabetes and emotional problems: long-term follow-up findings from the DiaMind randomized controlled trial. Journal of
    psychosomatic research. 2014 Jul 1;77(1):81-4.
    18. Tovote KA, Fleer J, Snippe E, Peeters AC, Emmelkamp PM, Sanderman R, Links TP, Schroevers MJ. Individual
    mindfulness-based cognitive therapy and cognitive behavior therapy for treating depressive symptoms in patients with
    diabetes: results of a randomized controlled trial. Diabetes care. 2014 Sep 1;37(9):2427-34.
    19. SamadZadeh N, Poursharifi H, Babapour J. Evaluation of the effectiveness of cognitive-behavioral therapy on
    psychosocial adjustment with disease and depressive symptoms in people with type II diabetes. Clinical Psychology
    Studies, 2015; 5 (17): 77-96.
    20. Ashoori J. The effect of cognitive behavioral therapy on happiness and mental health in patients with type II diabetes.
    IJPN. 2016; 3 (4) :71-79
    21. Wilz G, Barskova T. Evaluation of a cognitive behavioral group intervention program for spouses of stroke patients.
    Behaviour research and therapy. 2007 Oct 1;45(10):2508-17.
    22. Delavar A. Research Methods in Psychology and Educational Sciences. Tehran: Virayesh. 2019.
    23. Lotdi Kangarshahi A, Dehghani F, Rostami R, Ashraf Talesh H, Abolhasani M. Comparison of the effectiveness of
    cognitive-behavioral therapy with cognitive-based cognitive-cognitive therapy in increasing activity and weight loss in
    obese people with coronary heart disease. Journal of Health Psychology, 2019; 8 (31): 53-78.
    24. Guo J, Wang H, Luo J, Guo Y, Xie Y, Lei B, Wiley J, Whittemore R. Factors influencing the effect of mindfulness-based
    interventions on diabetes distress: a meta-analysis. BMJ Open Diabetes Research and Care. 2019 Dec 1;7(1).
    25. Bogusch LM, O'Brien WH. The effects of Mindfulness-based interventions on diabetes-related distress, quality of life, and
    metabolic control among persons with diabetes: A meta-analytic review. Behavioral Medicine. 2019 Jan 2;45(1):19-29.
    26. Hanson M., & Small M. Physician/patient reporting of depression/anxiety in a US pulmonary arterial hypertension
    population. 2019.
    27. Rosenzweig S, Reibel DK, Greeson JM, Edman JS, Jasser SA, McMearty KD, Goldstein BJ. Mindfulness-based stress
    reduction is associated with improved glycemic control in type 2 diabetes mellitus: a pilot study. Alternative Therapies in
    Health and Medicine. 2007 Sep 1;13(5):36-9.
    28. MohammadZadehFarhani1 A, Naderi2 F, Rajab3 A, Ahadi4 H, Kraskian5 A. Effectiveness of cognitive – behavioral
    therapy on psychological problems and Blood glucose control in children with diabetes mellitus type I. JPEN. 2018; 4 (3)
    :56-63
    29. Fouladvand M. The effectiveness of cognitive-behavioral therapy in the treatment of high school girls with obesity in
    Tehran. Master Thesis, Azad University, Science and Research Branch. 2013.
  2. 30. Cummings DM, Lutes LD, Littlewood K, Solar C, Carraway M, Kirian K, Patil S, Adams A, Ciszewski S, Edwards S,
    Gatlin P. Randomized Trial of a Tailored Cognitive Behavioral Intervention in Type 2 Diabetes With Comorbid
    Depressive and/or Regimen-Related Distress Symptoms: 12-Month Outcomes From COMRADE. Diabetes care. 2019 May
    1;42(5):841-8.
    31. Clarke J, Sanatkar S, Baldwin PA, Fletcher S, Gunn J, Wilhelm K, Campbell L, Zwar N, Harris M, Lapsley H, HadziPavlovic D. A web-based cognitive behavior therapy intervention to improve social and occupational functioning in adults
    with type 2 diabetes (The SpringboarD trial): Randomized controlled trial. Journal of medical Internet research.
    2019;21(5):e12246.
    32. Nagata S, Seki Y, Shibuya T, Yokoo M, Murata T, Hiramatsu Y, Yamada F, Ibuki H, Minamitani N, Yoshinaga N,
    Kusunoki M. Does cognitive behavioral therapy alter mental defeat and cognitive flexibility in patients with panic
    disorder?. BMC research notes. 2018 Dec;11(1):23.
    33. Gregg JA, Callaghan GM, Hayes SC, Glenn-Lawson JL. Improving diabetes self-management through acceptance,
    mindfulness, and values: a randomized controlled trial. Journal of consulting and clinical psychology. 2007 Apr;75(2):336.
    34. Schneider RH, Egan BM,
medical journal of mashhad university of medical sciences
Volume 63, Issue 3
July and August 2020
Pages 2414-2427

Files

Share

How to cite

Statistics